Navigation Links
Study examines the use of light in medical therapy
Date:3/30/2009

Santiago de Compostela, Spain March 30, 2009 A study published in a special issue of Photochemistry and Photobiology examines the emerging practice of drug delivery systems which use the application of light to activate medications in the body.

The process uses biocompatible materials that are sensitive to certain physiological variables or external physicochemical stimuli. Changes in external or internal body conditions can be used to achieve control of the delivery. There are drug delivery systems that can respond to small changes in light, temperature, pH or the concentration of specific substances.

Current research on the drug delivery systems is focused on developing systems capable of delivering the adequate dose of drug at the target site, avoiding collateral effects and enhancing the therapeutic efficiency. In the case of cancer, light-sensitive systems are particularly useful for direct treatment of malignant cells and minimizing damage to healthy cells.

External control of drug delivery offers a number of advantages. The process enables an easy and precise control of the medication. Switching the light on and off also triggers or stops the release of medication. This can often be done by the patient.

"Near-infrared (NIR) light is particularly useful as an agent capable of triggering the drug release," says Carmen Alvarez-Lorenzo, co-author of the study. "NIR is innocuous, does not cause significant heating in the area of its application and can be useful in the difficult to access areas of the body."


'/>"/>

Contact: Sean Wagner
journalnews@bos.blackwellpublishing.net
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1

Related medicine news :

1. Study examines effect of heart surgery on employment
2. Consumer Group Releases New Study About Defective Heart Devices and Implants; Patients Arrive in DC Tomorrow
3. Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers
4. Study Links Sugar Production in Yeast Cells to Longevity
5. Mayo study shows simple finger device may help predict future heart events, such as heart attack
6. Study shows that exercise reduces migraine suffering
7. Mayo Study Shows Simple Finger Device May Help Predict Future Heart Events, Such as Heart Attack
8. New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery
9. Autism Study Finds Significant Benefit with Hyperbaric Treatment
10. Danon Disease Can Be Quickly Fatal, Study Finds
11. NYU study finds new risk factor for melanoma in younger women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... People are starting to accept that hearing aids can be helpful and ... it had when great-grandpa wore his hearing aids years ago,” said Dr. Maura Marks, ... American Speaker Series (NASS) segment. “He probably wore an iPod-size hearing aid on ...
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a ... its Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, ... power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s ... is the premier online modeling resource for fluorescence microscopists and optical system designers, ... during last 5 years spanning the globe, SearchLight has become a tremendously popular ...
(Date:4/27/2017)... DC (PRWEB) , ... April 27, 2017 , ... ... Behavioral Economics Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking ... recognition (IRR) field. Offering practical takeaways to apply immediately to IRR programs, the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: